tert-Butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate

Catalog No. :
ACERNK694
CAS No. :
168960-18-7
Molecular Formula :
C11H19NO3
Molecular Weight :
213.28

IUPAC Name:tert-butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate

tert-Butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$53.00Login to see priceInquiryInquiry
5g97%$244.00Login to see priceInquiryInquiry
10g97%$356.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate
IUPAC Nametert-butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate
Molecular FormulaC11H19NO3
Molecular Weight213.28
SMILESO=C(OC(C)(C)C)N[C@H]1C=C[C@@H](CO)C1
InChI KeyMVIWPMBRXBNBDX-BDAKNGLRSA-N
Synonym168960-18-7 | tert-butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate | tert-butyl (1r,4s)-4-(hydroxymethyl)cyclopent-2-enylcarbamate | TERT-BUTYL N-[(1R,4S)-4-(HYDROXYMETHYL)CYCLOPENT-2-EN-1-YL]CARBAMATE | Carbamic acid, N-[(1R,4S)-4-(hydroxymethyl)-2
CAS No.168960-18-7
PubChem CID11052993

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACERNK694 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDGUA091 route compound structure diagram
    ACDGUA091168960-19-8 In Stock
  4. Then
  5. ACERNK694 route product structure diagram
    ACERNK694168960-18-7
Inquiry

2. ACERNK694 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACERNK694 route product structure diagram
    ACERNK694168960-18-7
Inquiry

Comments (0)